Oditrasertib

CAS No. 2252271-93-3

Oditrasertib( —— )

Catalog No. M36303 CAS No. 2252271-93-3

Oditrasertib (DNL-788) is a potent RIPKl inhibitor with an IC50 value of less than 100 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 141 In Stock
5MG 154 In Stock
10MG 226 In Stock
25MG 377 In Stock
50MG 535 In Stock
100MG 731 In Stock
200MG Get Quote In Stock
500MG 1479 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Oditrasertib
  • Note
    Research use only, not for human use.
  • Brief Description
    Oditrasertib (DNL-788) is a potent RIPKl inhibitor with an IC50 value of less than 100 nM.
  • Description
    Oditrasertib is a receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 value lower than 100 nM. Oditrasertib can be used for the research of diseases involving inflammation or cell death.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    RIP kinase
  • Recptor
    RIP kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2252271-93-3
  • Formula Weight
    295.28
  • Molecular Formula
    C14H15F2N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#CC1=CN=CC2=C1OCCN(C(=O)C(C)(C)C(F)F)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fidalgo JDV, et al. Preparation of substituted oxazepines and related compounds as RIPK1 inhibitors and uses thereof. WO2018213632A1. 2018-11-22.
molnova catalog
related products
  • GSK547

    GSK547 (RIP1i, GSK 547) is a highly selective and potent inhibitor of RIP1 kinase that robustly targets RIP1 in vivo.

  • RIPK2-IN-5

    RIPK2-IN-5 is a receptor-interacting protein kinase 2 (RIPK2) inhibitor with potential anti-inflammatory activity for the study of diseases caused by immune dysfunctions.

  • Eclitasertib

    Eclitasertib is a potent inhibitor of receptor-interacting protein kinase 1 (RIPK1, IC50 of <1 μΜ).